Suppr超能文献

肝脏X受体(LXR)与肝脏脂肪生成。碳水化合物反应元件结合蛋白是LXR的一个靶基因。

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.

作者信息

Cha Ji-Young, Repa Joyce J

机构信息

Department of Physiology, Touchstone Center for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

出版信息

J Biol Chem. 2007 Jan 5;282(1):743-51. doi: 10.1074/jbc.M605023200. Epub 2006 Nov 14.

Abstract

The liver X receptors, LXRalpha (NR1H3) and LXRbeta (NR1H2), are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. LXRs play a critical role in cholesterol homeostasis and bile acid metabolism. In addition, oral administration of LXR agonists to mice results in elevated hepatic fatty acid synthesis and steatosis and increased secretion of triglyceride-rich very low density lipoprotein resulting in hypertriglyceridemia. This increased hepatic lipogenesis has been largely attributed to the LXR-dependent up-regulation of sterol regulatory element-binding protein 1c (SREBP-1c) expression. However, it has been reported that treating Srebp-1c null mice with the synthetic LXR agonist T0901317 still results in enhanced expression of many lipogenic genes, suggesting additional mechanisms by which LXR can enhance hepatic lipogenesis. In this report, we identify the carbohydrate response element-binding protein (ChREBP) as an LXR target that independently enhances the up-regulation of select lipogenic genes. The ChREBP promoter contains functional LXR-binding sites that confer receptor-dependent binding and transactivation. We show that T0901317 treatment of mice is associated with up-regulation of the ChREBP target gene, liver-type pyruvate kinase. Therefore, activation of LXR not only increases ChREBP mRNA via enhanced transcription but also modulates ChREBP activity. This establishes LXR as a master lipogenic transcription factor, as it directly regulates both SREBP-1c and ChREBP to enhance hepatic fatty acid synthesis.

摘要

肝脏X受体LXRα(NR1H3)和LXRβ(NR1H2)是配体激活的转录因子,属于核激素受体超家族。LXR在胆固醇稳态和胆汁酸代谢中起关键作用。此外,给小鼠口服LXR激动剂会导致肝脏脂肪酸合成增加和脂肪变性,并增加富含甘油三酯的极低密度脂蛋白的分泌,从而导致高甘油三酯血症。这种肝脏脂肪生成的增加主要归因于LXR依赖性上调固醇调节元件结合蛋白1c(SREBP-1c)的表达。然而,有报道称,用合成LXR激动剂T0901317处理Srebp-1c基因敲除小鼠仍会导致许多脂肪生成基因的表达增强,这表明LXR增强肝脏脂肪生成的其他机制。在本报告中,我们确定碳水化合物反应元件结合蛋白(ChREBP)是LXR的一个靶点,它独立增强特定脂肪生成基因的上调。ChREBP启动子包含功能性LXR结合位点,可赋予受体依赖性结合和反式激活。我们发现,用T0901317处理小鼠与ChREBP靶基因肝型丙酮酸激酶的上调有关。因此,LXR的激活不仅通过增强转录增加ChREBP mRNA,还调节ChREBP活性。这确立了LXR作为主要脂肪生成转录因子的地位,因为它直接调节SREBP-1c和ChREBP以增强肝脏脂肪酸合成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验